New Initiative Urges Women to Address Men’s Health this New Year
experiences symptoms like fatigue, depressed mood and increased waistline it
could be related to a condition known as low testosterone, or Low T, according
to survey results announced today by Solvay Pharmaceuticals, Inc. For women
resolving to talk to their husbands or boyfriends about making their health a
priority this New Year, one important aspect to consider is low testosterone.
Solvay Pharmaceuticals, Inc. has introduced a toll-free number, 1-866-996-LowT
(5698), available through the end of January, and expanded Web site offerings
at www.IsItLowT.com to support women who are encouraging the men in their
lives to have an annual medical exam this year and consider talking about
symptoms that may be related to Low T.
The survey of women with husbands or male partners over 40, found that
women are twice as likely as men to prompt their partners to have an annual
medical exam. Further, 65 percent of women said that worrying about their
husband or male partner’s overall health will affect their anxiety levels in
2009, and one part of overall health is low testosterone, which also includes
symptoms such as fatigue, depression and sexual dysfunction. As women enter
the New Year with the men in their lives’ health in mind, these new tools
offer them easily-accessible information including a low testosterone
screener, tips on starting a conversation with men about Low T, facts on the
relationship between Type 2 diabetes and low testosterone, and treatment
options for low testosterone.
“Thirteen million men in the U.S. age 45 and older suffer from low
testosterone, but less than 10 percent are receiving treatment. Not enough men
are aware of what the symptoms are, and they should consider talking to a
their husband’s health; if they are better informed about the signs and
symptoms of treatable medical conditions such as low testosterone they can
help make a big impact in the health of their male partners.”
Survey Key Findings
— Women reported that time away from work would be the leading obstacle
keeping their husband or male partner from a doctor’s visit in 2009; more than
a quarter of women (27 percent) also said that fear and lack of motivation
would play a role in preventing a doctor’s visit.
— 82 percent of women responded that their spouse or male partner was
more likely to discuss changes in cardiovascular health, eyesight or hearing
with them after an annual medical exam than changes in weight or sexual
— Women were two times more likely to attribute symptoms, such as fatigue
and depressed mood, to thyroid disease or diabetes than to the possibility
that the men lives may be suffering from low testosterone.
— Not surprisingly, on average women report that the men in their lives
spend five times more hours a month watching television than addressing their
personal health; less than a quarter (21 percent) said that long-term health
is most important to their husband’s or male partner’s daily life.
“The New Year is the perfect opportunity for men to take time out to
address their overall health, including Low T, by having an annual medical
exam, and discussing any questions or concerns that they might have with their
physicians,” said Dr.
Affairs and chief medical officer, Solvay Pharmaceuticals, Inc. “We are
pleased to announce the launch of 1-866-996-LowT and www.IsItLowT.com as part
of our ongoing commitment to educating men and their loved ones about low
www.IsItLowT.com and 1-866-996-LowT provide fast and easy ways to learn
about Low T. These resources include an interactive quiz to determine a
patient’s potential for having Low T, ways to engage in conversations with a
doctor about symptoms associated with low testosterone, and a guide to help
women have a productive dialogue about low testosterone with the men in their
About the Survey
Solvay Pharmaceuticals, Inc. commissioned Opinion Research Corporation to
survey 406 women married or in a relationship with men over 40 years old to
assess the role women play in their partner’s health. The random phone survey
also explored respondents’ opinions about how well their male partner managed
his health in 2008 and his level of dedication to his health versus other
activities in his life.
The margin of error at a 95 percent confidence level is plus or minus 4.9
percentage points for the total sample in each survey. The study was
About Low Testosterone
It is estimated that hypogonadism, also known as low testosterone, affects
more than 13 million men in
and symptoms of low testosterone are subtle and often overlap with other
common medical conditions, low testosterone is frequently undiagnosed. Signs
and symptoms of low testosterone include low sex drive, erectile dysfunction,
fatigue, depressed mood, reduced muscle mass and strength, increased fat body
mass and decreased bone mineral density.
Men with chronic conditions, such as obesity, diabetes, high blood
pressure, high cholesterol and asthma/COPD, are also more likely to have low
testosterone compared to other men. Below normal levels of testosterone can be
confirmed by a blood test. Testosterone treatment is designed to elevate a
hypogonadal male’s testosterone levels into the normal physiologic range,
which may alleviate symptoms related to low testosterone. As with any
medication, patients should work with their physician to weigh treatment
benefits and risks.
— Do not use androgen therapy if:
– You are a man with known or suspected prostate cancer, or if you have
– You are a woman who is breastfeeding, pregnant, or may become
— Patients treated with androgens may be at an increased risk for
prostate cancer. Your doctor will likely monitor for prostate cancer before
and during treatment with androgens.
— Patients with benign prostatic hypertrophy (BPH) who are treated with
androgens are at an increased risk of worsening of BPH symptoms.
About Solvay Pharmaceuticals, Inc.
Solvay Pharmaceuticals, Inc., of
of Solvay Pharmaceuticals. For more information, visit
Solvay Pharmaceuticals is a research driven group of companies that
constitute the global pharmaceutical business of the Solvay Group. These
companies seek to fulfill carefully selected, unmet medical needs in the
therapeutic areas of neuroscience, cardio-metabolic, influenza vaccines,
gastroenterology, and men’s and women’s health. Its 2007 sales were
Solvay is an international chemical and pharmaceutical Group with
In 2007, its consolidated sales amounted to
three sectors of activity: Chemicals, Plastics and Pharmaceuticals. Solvay
(NYSE Euronext: SOLB.BE – Bloomberg: SOLB.BB – Reuters: SOLBt.BR) is listed on
the NYSE Euronext stock exchange in
An electronic press kit (EPK) is available at http://www.firstlinemedia.com/newyearsmenshealth. Contact: Jessica Riley Solvay Pharmaceuticals, Inc. (770) 578-5637 Dave Schemelia HealthStar Public Relations (609) 468-9325
SOURCE Solvay Pharmaceuticals, Inc.